Last updated on August 2013

Androgen Deprivation Therapy in Treating Patients With Prostate Cancer


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Prostate Cancer
  • Age: - 100 Years
  • Gender: Male
  • Other:
    DISEASE CHARACTERISTICS:
    Histologically confirmed adenocarcinoma of the prostate
    Prostate-specific antigen (PSA) relapse OR incurable disease diagnosed within the
    past 2 months AND meets criteria for either of the following groups:
    Group 1
    In PSA relapse after definitive radical treatment (prostatectomy or
    radiotherapy), as evidenced by 1 the following:
    Post-prostatectomy PSA level ≥ 0.2 ng/mL
    At least 3 rising PSA levels (post-radiotherapy) obtained ≥ 1 month
    apart, with the last PSA obtained within the past 2 months
    No metastatic disease by bone scan or abdomino-pelvic CT scan
    Group 2
    Not suitable for radical treatment at primary diagnosis
    Not planning to receive curative treatment
    Localized or metastatic disease
    No symptomatic disease requiring radiotherapy or immediate hormonal
    therapy
    No symptomatic disease requiring therapy
    PATIENT CHARACTERISTICS:
    Age
    Any age
    Performance status
    Not specified
    Life expectancy
    At least 5 years
    Hematopoietic
    Not specified
    Hepatic
    Not specified
    Renal
    Not specified
    Other
    No other significant comorbid condition that would limit life expectancy to < 5 years
    PRIOR CONCURRENT THERAPY:
    Biologic therapy
    Not specified
    Chemotherapy
    Not specified
    Endocrine therapy
    At least 12 months since prior androgen deprivation therapy (ADT) administered in the
    neoadjuvant or concurrent (with radiotherapy) setting (group 1)
    No prior ADT (group 2)
    Radiotherapy
    See Disease Characteristics
    See Endocrine therapy
    Surgery
    See Disease Characteristics
    Other
    No concurrent enrollment in TROG-96.01 or TROG-RADAR protocols

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.